Skip to main content
Signal8

Susman Robert Graham

SEC insider (Form 3/4/5 filer). CIK 0002065992. Director at Immunovant, Inc. (IMVT). 3 reported Form 4/5 transactions since Sep 2024; latest on May 1, 2026. Located in DURHAM, NC.

Companies Susman Robert Graham has filed insider reports for

  • Immunovant, Inc. (IMVT): Director
Susman Robert Graham profile photo

Susman Robert Graham

CIK: 0002065992

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immunovant, Inc. logo
IMVT

Immunovant, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    May 1, 2026
    Sale
    Direct
    2.5K shares at avg. $27.17$68K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 7, 2026
    Award
    Direct
    13.9K shares-
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    May 1, 2025
    Award
    Direct
    25K shares-

1-3 of 3